FEROX STRATEGIES

Lobbying for ELI LILLY AND COMPANY · American pharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Issues related to the pharmaceutical industry. Issues related to treating and reducing obesity. Issues related to drug shortages and counterfeit products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.